• Home

  • About Us

      About Us
      • Hycells Profile

      • Corporate Culture

      • Honors Qualifications

      • Contact Us

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Sample Service

      Sample Service
      • Immune Cells

      • Hepatocytes

      • Stem Cells

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Featured Products

      Featured Products
      • Cultivation Products

      • Testing Products

      • Other Products And Instruments

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Technical Service Platform

      Technical Service Platform
      • Specialized Sample Services

      • Conventional Drug Efficacy Evaluation

      • Granulocyte Function Experiment

      • Whole Blood/Serum Test

      • Drug Immunogenicity Testing

      • Drug Blood Toxicity Testing

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Technology Center

      Technology Center
      • Frequently Asked Questions

      • Operational Skills

      • Training Salon

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000
  • Blog

      Blog
      • Company News

      • Industry Trends

      • Laws Regulations

      营销与服务
      案例展示 留言咨询 联系我们
      业务咨询电话:
      0000-00000000

  • Language

    Language

    • 中文版

    • English

Confirm
Blog

Blog

Company News

Industry Trends

Laws Regulations

  • Position: Home page

All Categories >

Company News

Industry Trends

Laws Regulations

15

2021-09

Administrative Measures for Researcher-Initiated Clinical Research Conducted by Medical and Health Institutions (Trial)

Recently, the National Health Commission convened a kickoff meeting in Beijing for the pilot program on standardized management of clinical research in medical and health institutions, at which it officially released the Measures for the Administration of Investigator-Initiated Clinical Research Conducted by Medical and Health Institutions (Trial) and announced that the measures would be implemented on a pilot basis starting October 1, 2021, in Beijing, Shanghai, Guangdong Province, and Hainan Province.

2021-09-15

He Yousheng

15

2021-09

Genetic Office Announces Dates for Approval Meetings in the Second Half of 2021

To further enhance the quality of administrative approval services for human genetic resources and to enable applicants to better track the progress of their applications, the scheduled dates for the Administrative Licensing Review Meetings of the China Office for the Administration of Human Genetic Resources in the second half of 2021 are hereby announced. Should special circumstances necessitate adjustments to the meeting schedule, advance notice will be provided.

2021-09-15

He Yousheng

15

2021-09

Q&A with Journalists on the Regulations of the People’s Republic of China on the Administration of Human Genetic Resources

On May 28, 2019, Premier Li Keqiang signed State Council Order No. 717, promulgating the Regulations of the People’s Republic of China on the Administration of Human Genetic Resources (hereinafter referred to as the “Regulations”). The Regulations came into effect on July 1, 2019. Recently, officials from the Ministry of Justice and the Ministry of Science and Technology answered questions from reporters on matters related to the Regulations.

2021-09-15

He Yousheng

15

2021-09

Contact Information for Human Genetic Resource Management

2021-09-15

He Yousheng

15

2021-09

Regulations of the People’s Republic of China on the Administration of Human Genetic Resources

Article 1 This Regulation is formulated to effectively protect and rationally utilize China’s human genetic resources, and to safeguard public health, national security, and the public interest.

2021-09-15

He Yousheng

15

2021-09

Biosecurity Law of the People’s Republic of China

The Biosecurity Law of the People’s Republic of China was adopted at the 22nd Session of the Standing Committee of the 13th National People’s Congress on October 17, 2020, and came into force on April 15, 2021.

2021-09-15

He Yousheng
< 1...21222324 >

Contact Us

Phone: 021-36696819

Mobile phone:13061948224(Ms. Yu)

Email:monika@hys-bio.com

Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City

Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai

图片名称

Official Website

图片名称

WeChat Official Account

  • Home

  • About Us

    • Hycells Profile

    • Corporate Culture

    • Honors Qualifications

    • Contact Us

  • Sample Service

    • Immune Cells

    • Hepatocytes

    • Stem Cells

  • Featured Products

    • Cultivation Products

    • Testing Products

    • Other Products And Instruments

  • Technical Service Platform

    • Specialized Sample Services

    • Conventional Drug Efficacy Evaluation

    • Granulocyte Function Experiment

    • Whole Blood/Serum Test

    • Drug Immunogenicity Testing

    • Drug Blood Toxicity Testing

  • Technology Center

    • Frequently Asked Questions

    • Operational Skills

    • Training Salon

  • Blog

    • Company News

    • Industry Trends

    • Laws Regulations


All rights reserved by Hycells Biotechnology Co., Ltd. www.300.cn SEO

Business License

Message Board

Submit
%{tishi_zhanwei}%
中企跨境-全域组件 2.0.1 制作前进入CSS配置样式

E-mail:

Ms. Yu:

导航下拉添加类名.active

在线客服添加返回顶部

屏蔽页面上图片的alt/title提示

右侧在线客服样式 1,2,3 1

图片alt标题设置: Hycells

表单验证提示文本: Content cannot be empty!

循环体没有内容时: Sorry, no matching items were found.

CSS / JS 文件放置地